Tweets by Advanced Cancer Therapies

Icon Legend

Type here to filter the list

Sunday, Feb 18th
12:40 PM - 12:50 PM AST
41: Elucidating the tumor microenvironment in desmoplastic melanoma using digital spatial profiling
Location: Miramar I & II
Abstract Presenter: james clune, MD – Yale New Haven Hospital
Author: David g. Su, 1144849480 – Yale New Haven Hospital
Author: David Schoenfeld, M.D. Ph.D. – Yale New Haven Hospital
Author: Wael Ibrahim, M.D. – Yale New Haven Hospital
Author: Raysa Cabrejo, M.D. – Dartmouth Hitchcock Medical Center
Author: David Rimm, M.D. Ph.D. – Yale New Haven Hospital
Author: sajid Khan, M.D. – Yale New Haven Hospital
Author: harriet Kluger, M.D. – Yale New Haven Hospital
Author: Kelly Olino, MD (she/her/hers) – Yale School of Medicine, Department of Surgery
Author: anjela galan, M.D. – Yale New Haven Hospital
MelanomaApplied Research
Sunday, Feb 18th
1:00 PM - 2:00 PM AST
Management of Regional Disease in Melanoma and Cutaneous SCC
Location: Miramar I & II
Moderator: Michael C. Lowe, MD, MA – Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University
MelanomaCME
Sunday, Feb 18th
2:35 PM - 2:40 PM AST
P19: Systemic and Locoregional Efficacy of Talimogene laherparapvec in Advanced Melanoma
Location: Miramar I & II
Oral Poster Presenter: Aparna Vancheswaran, MD – Memorial Sloan Kettering Cancer Center
Submitter: Aparna Vancheswaran, MD – Memorial Sloan Kettering Cancer Center
Author: Aparna Vancheswaran, MD – Memorial Sloan Kettering Cancer Center
Author: Shanie Shemla, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center
Author: Jared Theriot, MD – Memorial Sloan Kettering Cancer Center
Author: Danielle M. Bello, MD – MSKCC
Author: Edmund Bartlett, MD – MSKCC
Author: Charlotte Ariyan, MD, PhD, FACS – Memorial Sloan Kettering Cancer Center
Melanoma
Sunday, Feb 18th
2:40 PM - 2:45 PM AST
P20: Patterns of Recurrence after Adjuvant Treatment in Melanoma and Factors Predicting Recurrence
Location: Miramar I & II
Oral Poster Presenter: Derek Effiom, MBBS – Massachusetts General Brigham
Submitter: Derek Effiom, MBBS – Massachusetts General Brigham
Author: Derek Effiom, MBBS – Massachusetts General Brigham
Author: Asra Alimohamed, MD – Massachusetts General Hospital
Author: Emma Specht, BA (she/her/hers) – Massachusetts General Hospital
Author: Aikaterini Dedeilia, MD (she/her/hers) – Massachusetts General Hospital
Author: Tatyana Sharova, MD – Massachusetts General Hospital
Author: Aleigha Lawless, BA – Massachusetts General Hospital
Author: Sonia Cohen, MD PhD – Massachusetts General Hospital/Harvard Medical School
Author: Genevieve M. Boland, MD, PhD (she/her/hers) – Massachusetts General Hospital
Melanoma
Sunday, Feb 18th
2:45 PM - 2:50 PM AST
P17: Management of Anorectal Melanoma in the Era of Modern Systemic Therapies
Location: Miramar I & II
Oral Poster Presenter: Adrienne B. Shannon, MD – H. Lee Moffitt Cancer Center and Research Institute
Submitter: Adrienne B. Shannon, MD – H. Lee Moffitt Cancer Center and Research Institute
Author: Adrienne B. Shannon, MD – H. Lee Moffitt Cancer Center and Research Institute
Author: Matthew C. Perez, MD – H. Lee Moffitt Cancer Center and Research Institute
Author: Evan J. Wuthrick, MD, MD – H. Lee Moffitt Cancer Center and Research Institute
Author: Seth I. Felder, MD – H. Lee Moffitt Cancer Center and Research Institute
Author: Ricardo J. Gonzalez, MD – H. Lee Moffitt Cancer Center and Research Institute
Author: Vernon K. Sondak, MD (he/him/his) – H. Lee Moffitt Cancer Center and Research Institute
Author: Julian A. Sanchez, MD (he/him/his) – H. Lee Moffitt Cancer Center and Research Institute
Author: Jonathan S. Zager, MD – H. Lee Moffitt Cancer Center and Research Institute
Melanoma
Sunday, Feb 18th
2:50 PM - 2:55 PM AST
P18: A Single Institution Experience Using Ultrasound-Guided Intralesional Immunotherapy in Recurrent Melanoma
Location: Miramar I & II
Oral Poster Presenter: Olivia P. Waldron, BS – Pennsylvania State University
Submitter: Olivia P. Waldron, BS – Pennsylvania State University
Author: Olivia P. Waldron, BS – Pennsylvania State University
Author: Joanna T. Buchheit, MD (she/her/hers) – Penn State Health Milton S. Hershey Medical Center
Author: Colette R. Pameijer, MD (she/her/hers) – Penn State College of Medicine
Melanoma
Sunday, Feb 18th
3:00 PM - 4:30 PM AST
Melanoma Workshop: Multidisciplinary Approach to the Management of Hepatic Dominant Uveal Melanoma Metastases
Location: Miramar I & II
Moderator: Michael C. Lowe, MD, MA – Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University
Melanomanon-CME
Monday, Feb 19th
8:10 AM - 8:20 AM AST
32: Isolated Limb Infusion as First, Second, or Third-Line Therapy for Melanoma with In-Transit Metastasis
Location: Miramar I & II
Abstract Presenter: Aleena Boby, B.A. (she/her/hers) – University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL
Submitter: Aleena Boby, B.A. (she/her/hers) – University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL
Author: Aleena Boby, B.A. (she/her/hers) – University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL
Author: Michelle M. Dugan, MD – Cutaneous Oncology Department, Moffitt Cancer Center, Tampa, FL
Author: Helana Ghali, BS – University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL
Author: Shaliz Aflatooni, BS (she/her/hers) – University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL
Author: Danielle K. DePalo, MD (she/her/hers) – Department of General Surgery, University of Massachusetts Chan Medical School, Boston, MA
Author: Wenyi Fan, MSPH – Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa FL
Author: Jonathan S. Zager, MD – H. Lee Moffitt Cancer Center and Research Institute
Melanoma
Monday, Feb 19th
8:20 AM - 8:30 AM AST
33: CD26 is a biomarker that can enhance response to T cell therapy in advanced melanoma
Location: Miramar I & II
Abstract Presenter: Shannon K. Swisher, MD (she/her/hers) – Department of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
Submitter: Shannon K. Swisher, MD (she/her/hers) – Department of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
Author: Shannon K. Swisher, MD (she/her/hers) – Department of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
Author: Megan M. Wyatt, MS – Division of Surgical Oncology, Department of Surgery, Department of Microbiology and Immunology, Winship Cancer Institute, Emory University
Author: Megen C. Wittling, MSTP – Division of Surgical Oncology, Department of Surgery, Department of Microbiology and Immunology, Winship Cancer Institute, Emory University
Author: Ayana T. Ruffin, PhD – Division of Surgical Oncology, Department of Surgery, Department of Microbiology and Immunology, Winship Cancer Institute, Emory University
Author: Keith A. Delman, MD (he/him/his) – Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University
Author: Gregory B. Lesinski, PhD, MPH – Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University
Author: Michael C. Lowe, MD, MA – Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University
Author: Chrystal M. Paulos, PhD – Division of Surgical Oncology, Department of Surgery, Department of Microbiology and Immunology, Winship Cancer Institute, Emory University
Melanoma
Monday, Feb 19th
8:30 AM - 8:40 AM AST
34: Macrophage function over phenotype determines sensitization to immunotherapy in melanoma
Location: Miramar I & II
Abstract Presenter: David Lee, B.A. – Loma Linda University School of Medicine
Submitter: David Lee, B.A. – Loma Linda University School of Medicine
Author: Saurabh Sharma, Ph.D. – Stanford University
Author: Mamatha Serasanambati, Ph.D. – Stanford University
Author: M. Usman Ahmad, MD (he/him/his) – Stanford University
Author: Banafshe Larijani, n/a – University of Bath
Author: Amanda R. Kirane, MD, PhD (she/her/hers) – Stanford University
Melanoma
Monday, Feb 19th
8:40 AM - 8:50 AM AST
35: Hepatic and Overall Progression-Free Survival after Percutaneous Hepatic Perfusion as First-Line or Second-Line Therapy for Metastatic Uveal Melanoma
Location: Miramar I & II
Presenter: Helana Ghali, BS – University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL
Abstract Presenter: Helana Ghali, BS – University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL
Author: Helana Ghali, BS – University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL
Author: Michelle M. Dugan, MD – Cutaneous Oncology Department, Moffitt Cancer Center, Tampa, FL
Author: Shaliz Aflatooni, BS (she/her/hers) – University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL
Author: Aleena Boby, B.A. (she/her/hers) – University of South Florida Morsani College of Medicine, University of South Florida, Tampa, FL
Author: Danielle K. DePalo, MD (she/her/hers) – Department of General Surgery, University of Massachusetts Chan Medical School, Boston, MA
Author: Jose Laborde, PhD – Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa FL
Author: Jonathan S. Zager, MD – H. Lee Moffitt Cancer Center and Research Institute
Melanoma
Monday, Feb 19th
8:50 AM - 9:00 AM AST
36: Development of Functional Biomarker Assays: Analysis of Neoadjuvant Intralesional Oncolytic Virus Response in High-Risk Stage II Melanoma
Location: Miramar I & II
Abstract Presenter: Amanda R. Kirane, MD, PhD (she/her/hers) – Stanford University
Author: Amanda R. Kirane, MD, PhD (she/her/hers) – Stanford University
Submitter: David Lee, B.A. – Loma Linda University School of Medicine
Author: M. Usman Ahmad, MD (he/him/his) – Stanford University
Author: Saurabh Sharma, Ph.D. – Stanford University
Author: Mamatha Serasanambati, Ph.D. – Stanford University
Author: Michael C. Lowe, MD, MA – Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University
Author: Christopher Applebee, Ph.D. – University of Bath
Author: Elena Safrygina, Ph.D. – University of Bath
Author: Susan Swetter, M.D. – Stanford University
Author: Sunil Reddy, M.D. – Stanford University
Author: Alison Warner, M.D., Ph.D. – Stanford University
Author: Pauline Funchain, M.D. – Stanford University
Author: Jennifer Wang, M.D. – Stanford University
Author: Ronald Levy, M.D. – Stanford University
Author: Banafshe Larijani, n/a – University of Bath
Author: Emanual Maverakis, M.D. – UC Davis
Melanoma